Abiraterone Acetate
NDC 75907-224, Abiraterone Acetate, tablet, from Dr. Reddys Laboratories Inc.
- Product NDC
- 75907-224
- Status
- Listed
- Labeler
- Dr. Reddys Laboratories Inc
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208416
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/75907-224 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ABIRATERONE ACETATE250 mg/1
Pharmacologic classes
Cytochrome P450 17A1 Inhibitor [EPC]; Cytochrome P450 17A1 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 75907-224-04 | 75907022404 | 120 TABLET in 1 BOTTLE (75907-224-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0c91aa38-3b0a-232c-8eb1-55f08e8e6644NADAC price for package 75907022404
GET /v1/drugs/nadac/75907022404
Use it
Look up 75907-224 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/75907-224 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 75907-224. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.